Earnings, Sales Beat Expectations
Tiffany reported first-quarter earnings of $0.70 a share on sales of $895.48 million. Analysts had only expected $0.52 and $855 million, respectively. TIF rallies more than 6 percent before the bell on my tradeMONSTER platform.
Huge Premium For Omthera Pharma
AstaZeneca agreed to purchase Omthera Pharmaceuticals for $443 million to grow its heart-drug lineup. The deal values OMTH at $12.70 a share, and includes another $4.70 of upside if the company's Epanova drug succeeds. OMTH rockets 99 percent in the premarket.
Canadian Solar Crushes Revenue Estimates
Canadian Solar reported a first-quarter loss of just $0.49 a share, narrower than the $0.78 expected by analysts. Revenue of $325.8 million also crushed the $221 million estimate. CSIQ rallies 24 percent in early trading.
More From optionMONSTER